my Smart COPD exacerbation management

  • Ainsworth, Ben (PI)

Project: Central government, health and local authorities

Project Details


Background : Chronic obstructive pulmonary disease (COPD) is a common disease and is predicted to become the 3rd leading cause of death by 2030. Because there is no cure, treatment involves long-term management of symptoms to slow the decline of patient health and improve quality of life. A key characteristic of COPD is the presence of 'exacerbation events' defined as an acute worsening of symptoms. Exacerbation events are detrimental to health and often lead to hospitalization. Avoiding exacerbation events is desirable because it leads to higher quality of and longer life. Our recent pilot demonstrated that machine learning can predict acute exacerbation events several days in advance. Such predictions have huge potential to improve clinical models and drive behavioural change necessary to avoid acute exacerbation. Aims : We aim to predict COPD exacerbation events and use them to trigger interventions. The objectives are to 1) develop safe and reliable AI, 2) ensure acceptance and engagement with patients and clinicians, 3) establish clinical efficacy, safety, regulatory data, 4) establish a competitive AI-enhanced digital health ecosystem. Workplan : Four work packages will address clinical, technical and adoption. WP1 Person-Centred Care will create patient journey and clinical model, and work with clinicians, patients, and the public to ensure effectiveness and safety. WP2 Agile Digital Platform Engineering will develop a digital platform that incorporates AI components from WP3 Predictive Analytics and Visualisation . Finally, WP4 Dissemination, Certification and NHS Adoption will engage stakeholders, obtain regulatory approvals, and secure investment. Impact: By predicting and mitigating exacerbations, we aim to empower patients to engage with the management of their COPD and reduce the burden on NHS services. Exacerbation frequency/severity is expected to be reduced, slowing deterioration of lung function, and increasing quality of life. ROI is anticipated from reduced use of acute care and better use of medical interventions.
Effective start/end date1/09/2131/08/24


  • National Institute for Health Research


Explore the research topics touched on by this project. These labels are generated based on the underlying awards/grants. Together they form a unique fingerprint.